Cognitive-Behavioral Therapy for Adults With ADHD: A Qualitative Study

• Sponsor: Karolinska Institutet (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05037903
• Collaborator: (none)
• Enrollment: 20
• Location: 1
• Arm: 1
• Anticipated Duration (Months): 18
• Patients Per Site Per Month: 1.1

Study Details

Study Description

Brief Summary

This is a qualitative study of participants who have taken part in a randomized controlled trial (RCT) of a new treatment protocol based on cognitive-behavioral therapy for adults with attention deficit/hyperactivity disorder predominantly inattentive presentation. The purpose of the qualitative study is to explore participant perceptions of taking part in the RCT to further develop and improve the new treatment protocol.

Condition or Disease	Intervention/Treatment	Phase
Attention Deficit Hyperactivity Disorder	Behavioral: Cognitive-behavioral therapy	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 20 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation: A Qualitative Study
• Actual Study Start Date: Jul 1, 2021
• Anticipated Primary Completion Date: Dec 31, 2022
• Anticipated Study Completion Date: Dec 31, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Cognitive-behavioral therapy Cognitive-behavioral therapy, including behavioral exercises and homework assignments.	Behavioral: Cognitive-behavioral therapy; Cognitive and behavioral interventions aimed at increasing behavioral activation, and reducing procrastination and inattentive symptoms.

Outcome Measures

Primary Outcome Measures

1. Qualitative interview data [45-60 minutes]

   Participant responses based on questions posed in an interview

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Principal diagnosis of ADHD inattentive presentation

• 18 years of age or older

• If on medication, it needs to be well-established since three months, and

• Prior psycho-educational intervention

Exclusion Criteria:

• Intellectual impairment

• Substance use disorder

• Difficulties in adherence to medical or other treatment

• Social and/or psychiatric problems to such an extent that they prevent focusing on treatment, or

• Simultaneous psychological treatment

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Stockholm Health Care Services, Region Stockholm	Stockholm		Sweden

Sponsors and Collaborators

• Karolinska Institutet

Investigators

• Principal Investigator: Benjamin Bohman, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Benjamin Bohman, Study Principal Investigator, Karolinska Institutet
• ClinicalTrials.gov Identifier: NCT05037903
• Other Study ID Numbers: KI-2021-01663
• First Posted: Sep 8, 2021
• Last Update Posted: Aug 17, 2022
• Last Verified: Aug 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Hyperkinesis; Attention Deficit Disorder with Hyperactivity

Study Results

No Results Posted as of Aug 17, 2022